CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations

3.5.2. Restraints

3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness

3.5.3. Opportunities

3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy

CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Mechanical thrombectomy devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Aspiration thrombectomy devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Rheolytic thrombectomy devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Automated thrombectomy devices

5.2.1. Market size and forecast

5.3. Manual thrombectomy devices

5.3.1. Market size and forecast

CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE

6.1. Overview

6.1.1. Market size and forecast

6.2. Neurovascular thrombectomy devices

6.2.1. Market size and forecast

6.3. Peripheral thrombectomy devices

6.3.1. Market size and forecast

6.4. Coronary thrombectomy devices

6.4.1. Market size and forecast

CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY

7.1. Overview

7.1.1. Market size and forecast

7.2. Reusable thrombectomy devices

7.2.1. Market size and forecast

7.3. Disposable thrombectomy devices

7.3.1. Market size and forecast

CHAPTER 8: COMPANY PROFILES

8.1. BOSTON SCIENTIFIC CORPORATION

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. JOHNSON & JOHNSON

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. MEDTRONIC PLC

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. Stryker Corporation

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development

8.5. Teleflex Incorporated

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development

8.6. TERUMO MEDICAL CORPORATION

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development

8.7. KONINKLIJKE PHILIPS N.V.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments

8.8. Angiodynamics Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance

8.9. Penumbra, Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Capture Vascular, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio